HRT Financial’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
VPM
VCM
HRT Financial's IONS Position: Q1 2026 in Review
HRT Financial increased its Ionis Pharmaceuticals (IONS) stake by 1,000% in Q1 2026, buying an estimated $18.1M and bringing the position to 252,250 shares worth $18.9M. The position accounts for 0.05% of the portfolio, ranked #352.
HRT Financial first reported a position in IONS in Q3 2019 and has held it in 13 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- HRT Financial held 252,250 shares of Ionis Pharmaceuticals worth $18.9M as of Q1 2026.
- HRT Financial bought 229,322 Ionis Pharmaceuticals shares in Q1 2026, an estimated $18.1M.
- Ionis Pharmaceuticals made up 0.05% of HRT Financial's portfolio in Q1 2026, its #352 holding.
- HRT Financial first reported a position in Ionis Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.